Dr Reddys Laboratories Share Price Today - Live Blog for May 09, 2025

Dr Reddys Laboratories Ltd's shares saw an increase of 0.56%, reaching the current market price of ₹1,160.10. This development underscores the stock's growing popularity.

The share price of Dr Reddys Laboratories Ltd plunged by -0.24%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,153.75, but investors are assessing whether this is a temporary dip or a long-term trend.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.88%, reaching a current market price of ₹1,155.40. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Dr Reddys Laboratories Ltd's share price rallied by 0.59%, reaching the current market price of ₹1,163.65. This surge is indicative of the stock's recent positive performance.

Dr Reddys Laboratories Ltd witnessed a notable 0.28% surge in its share price and is presently trading at ₹1,154.45, captivating the attention of market participants.

The stock of Dr Reddys Laboratories Ltd suffered a -0.08% drop, and it's now trading at ₹1,150.30 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.23% upswing, and it's currently trading at ₹1,150.60 per share. Investors are closely watching this development.

Dr Reddys Laboratories Ltd witnessed a -0.12% decrease in its share price, and it is currently trading at ₹1,146.75. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 17.8500, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

Dr Reddys Laboratories Ltd's stock has surged by 0.17%, and it is currently trading at ₹1,149.00. Additionally, the stock maintains a PE ratio of 17.8500, while the industry PE is 34.0762.

Dr Reddys Laboratories Ltd's share price rallied by 0.27%, reaching the current market price of ₹1,147.05. This surge is indicative of the stock's recent positive performance.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.03%, reaching a current market price of ₹1,143.05. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.06%, and as of now, it's trading at ₹1,144.45 per share. This upward trajectory is attracting keen interest from investors.

With a -0.37% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,141.25. This development raises questions about the factors behind the decline. The stock's PE ratio is 17.8500, while the industry PE is 34.0762.

Dr Reddys Laboratories Ltd stock price decreased by -0.11%, with the current market value at ₹1,145.65 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.04% upswing, and it's currently trading at ₹1,144.50 per share. Investors are closely watching this development.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.10%, reaching a current market price of ₹1,144.00. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.22%, reaching the current market price of ₹1,145.40. This development underscores the stock's growing popularity.

After a significant 0.32% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,145.10 in the current market. This upward movement is attracting attention from both retail and institutional investors.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.18% increase and currently trading at ₹1,141.30 per share. Investors are taking notice of this upward momentum.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.18% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,141.30 per share. The stock has an ROE of 17.3623% and debt to equity ratio of 0.1579.

Dr Reddys Laboratories Ltd's share price has dropped by -0.06%, a development that warrants careful analysis. Presently trading at ₹1,140.60, investors are assessing whether this presents an opportunity or a risk.

Dr Reddys Laboratories Ltd observed a -0.05% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,141.10. The stock has a PE ratio of 17.8500, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

Dr Reddys Laboratories Ltd stock price decreased by -0.33%, with the current market value at ₹1,143.20 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd's share price has dropped by -0.19%, a development that warrants careful analysis. Presently trading at ₹1,147.80, investors are assessing whether this presents an opportunity or a risk.

Dr Reddys Laboratories Ltd's shares saw an increase of 0.20%, reaching the current market price of ₹1,148.45. This development underscores the stock's growing popularity.

After a notable 4.46% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,149.05. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1579 and an ROE of 17.3623%.